These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10347197)

  • 1. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.
    Ried S; Jäger C; Jeffers M; Vande Woude GF; Graeff H; Schmitt M; Lengyel E
    J Biol Chem; 1999 Jun; 274(23):16377-86. PubMed ID: 10347197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras.
    Lengyel E; Stepp E; Gum R; Boyd D
    J Biol Chem; 1995 Sep; 270(39):23007-12. PubMed ID: 7559439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
    Lengyel E; Gum R; Stepp E; Juarez J; Wang H; Boyd D
    J Cell Biochem; 1996 Jun; 61(3):430-43. PubMed ID: 8761947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2.
    Besser D; Bardelli A; Didichenko S; Thelen M; Comoglio PM; Ponzetto C; Nagamine Y
    Oncogene; 1997 Feb; 14(6):705-11. PubMed ID: 9038378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
    Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells.
    Moriyama T; Kataoka H; Hamasuna R; Yoshida E; Sameshima T; Iseda T; Yokogami K; Nakano S; Koono M; Wakisaka S
    Clin Exp Metastasis; 1999; 17(10):873-9. PubMed ID: 11089886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2.
    D'Orazio D; Besser D; Marksitzer R; Kunz C; Hume DA; Kiefer B; Nagamine Y
    Gene; 1997 Nov; 201(1-2):179-87. PubMed ID: 9409785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene.
    Lengye E; Singh B; Gum R; Nerlov C; Sabichi A; Birrer M; Boyd D
    Oncogene; 1995 Dec; 11(12):2639-48. PubMed ID: 8545121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.
    Naldini L; Tamagnone L; Vigna E; Sachs M; Hartmann G; Birchmeier W; Daikuhara Y; Tsubouchi H; Blasi F; Comoglio PM
    EMBO J; 1992 Dec; 11(13):4825-33. PubMed ID: 1334458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma.
    Abounader R; Ranganathan S; Kim BY; Nichols C; Laterra J
    J Neurochem; 2001 Mar; 76(5):1497-508. PubMed ID: 11238734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of urokinase expression by TNF-alpha requires the activation of binding sites for the AP-1 and PEA3 transcription factors.
    Lengyel E; Klostergaard J; Boyd D
    Biochim Biophys Acta; 1995 Jul; 1268(1):65-72. PubMed ID: 7626664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts.
    Besser D; Presta M; Nagamine Y
    Cell Growth Differ; 1995 Aug; 6(8):1009-17. PubMed ID: 8547215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network.
    Jeffers M; Rong S; Vande Woude GF
    Mol Cell Biol; 1996 Mar; 16(3):1115-25. PubMed ID: 8622656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
    Seol DW; Chen Q; Zarnegar R
    Oncogene; 2000 Feb; 19(9):1132-7. PubMed ID: 10713700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
    Paciucci R; Vilá MR; Adell T; Díaz VM; Torà M; Nakamura T; Real FX
    Am J Pathol; 1998 Jul; 153(1):201-12. PubMed ID: 9665481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules.
    Gum R; Juarez J; Allgayer H; Mazar A; Wang Y; Boyd D
    Oncogene; 1998 Jul; 17(2):213-25. PubMed ID: 9674706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.
    Wojta J; Kaun C; Breuss JM; Koshelnick Y; Beckmann R; Hattey E; Mildner M; Weninger W; Nakamura T; Tschachler E; Binder BR
    Lab Invest; 1999 Apr; 79(4):427-38. PubMed ID: 10211995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.
    Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Lee HJ; Eun JY; Kim HG; Yoon SS; Lee DS; Kim JH; Kim JR
    Clin Exp Metastasis; 2008; 25(1):89-96. PubMed ID: 17992475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma.
    Gao CF; Xie Q; Zhang YW; Su Y; Zhao P; Cao B; Furge K; Sun J; Rex K; Osgood T; Coxon A; Burgess TL; Vande Woude GF
    Mol Cancer Ther; 2009 Oct; 8(10):2803-10. PubMed ID: 19825800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA; Merlino G
    Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.